Unlock instant, AI-driven research and patent intelligence for your innovation.

17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds

A technology of fluoroalkyl steroids and drugs, which is applied in the field of 17-fluoromethyl steroids and can solve the problems of ignorance of 17-pentafluoroethyl-alkylated steroids

Inactive Publication Date: 2007-03-21
SCHERING AG
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

No known 17-pentafluoroethyl-alkylated steroids of the estane or androstane series

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds
  • 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds
  • 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0172] 17β-Hydroxy-17α-trifluoromethyl-androst-4-en-3-one

[0173] 10 g of 3β-acetoxy-DHEA was dissolved in 300 ml of THF, and mixed with 0.5 g of tetrabutylammonium fluoride. While stirring at room temperature, 15 ml of trifluoromethyltrimethylsilane was slowly added dropwise, followed by stirring for 3 hours. Next, 200 ml of semi-concentrated sodium bicarbonate solution was added, and THF was distilled off in vacuo. The residue was extracted three times with 100 ml of ethyl acetate. The combined organic extracts are dried, concentrated by evaporation and chromatographed on silica gel. 12 g of 3β-acetoxy-17β-trimethylsilyloxy-17α-trifluoromethyl-androst-5-ene are obtained.

[0174]Dissolve 12 g of 3β-acetoxy-17β-trimethylsilyloxy-17α-trifluoromethyl-androst-5-ene in 100 ml of THF, then mix with 20 ml of 30% hydrofluoric acid at room temperature mix. After 3 hours, it is poured into 200 ml of 12% ammonia solution, extracted with ethyl acetate (3*100 ml), the organic extra...

Embodiment 2

[0178] 17β-Hydroxy-17α-trifluoromethyl-7α-methyl-androst-4-en-3-one

[0179] 7 g of 17β-hydroxy-17α-trifluoromethyl-androst-4-en-3-one were refluxed with 8.5 g of chloranil in 200 ml of tert-butanol for 30 minutes. Allow to cool, then evaporate to dryness. The residue is chromatographed on silica gel. For further purification, recrystallize from dichloromethane / hexane. 17β-Hydroxy-17α-trifluoromethyl-androst-4,6-dien-3-one is obtained.

[0180] 1 H-NMR: 1.04(s, 3H, H-18), 1.13(s, 3H, H-19), 5.69(s, 1H, H-4), 6.11(m, 2H, H-6, H-7 )

[0181] 19 F-NMR: -75.3

[0182] Add 80ml of THF to a methylmagnesium iodide solution (prepared from 2.5g of magnesium and 6.4ml of iodomethane in 80ml of ether), cool to -5°C, and then add 1 g copper acetate monohydrate. After cooling to -20°C, a solution of 5 g of 17β-hydroxy-17α-trifluoromethyl-androst-4,6-dien-3-one in 80 ml of THF was added dropwise. After 2 hours it was poured into ice water / 2N sulfuric acid and extracted with ethyl ...

Embodiment 3

[0186] 17β-Hydroxy-17α-trifluoromethyl-4-chloro-androst-4-en-3-one

[0187] step 1

[0188] 17β-Hydroxy-17α-trifluoromethyl-4ξ,5ξ-epoxy-androstan-3-one

[0189] 2 g of 17β-hydroxy-17α-trifluoromethyl-androst-4-en-3-one were dissolved in 120 ml of methanol and 70 ml of THF and mixed with 20 ml of hydrogen peroxide solution (35%) at 10°C. While stirring, 5 ml of 10% sodium hydroxide solution was added, followed by stirring for 3 hours. The reaction solution was concentrated by evaporation to 50 ml, then mixed with 50 ml of dichloromethane and 25 ml of water, and the organic phase was separated. Washed with semi-concentrated thiosulfate, dried and evaporated to dryness. The resulting residue consisted of a mixture of 4α,5α- or 4β,5β-epoxides and was used in the next step without further purification.

[0190] step 2

[0191] 17β-Hydroxy-17α-trifluoromethyl-4-chloro-androst-4-en-3-one

[0192] 2 g of the epoxide mixture (step 1) were dissolved in 200 ml of acetone and mixed ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to 17 alpha fluoroalkyl steroids of the general formula (I), STEROID (I), wherein R3 represents a group of the formula CnFmHo, wherein n = 1, 2, 3, 4, 5 or 6, m > 1 and m+o = 2n+1. The invention further relates to methods for producing the same and to compositions that contain said compounds. The inventive composition of the general formula (I) possess androgenic activity.

Description

technical field [0001] The present invention relates to 17-fluoromethyl steroids, processes for their preparation and pharmaceutical compositions comprising these compounds. The compounds according to the invention have androgenic activity. Background technique [0002] 17-Perfluoroalkylated compounds of the estane series and 13-ethyl-sterane (gonane) series are known. 17β-hydroxy-17α-trifluoromethyl-estr-4-en-3-one, 17β-hydroxy-17α-trifluoromethyl-estr-4,9-dien-3-one and 17β-hydroxy-17α -Trifluoromethyl-estra-4,9,11-trien-3-one, 13-ethyl-17β-hydroxy-17α-trifluoromethyl-ster-4-en-3-one, 13-ethyl Base-17β-hydroxy-17α-trifluoromethyl-ster-4,9-dien-3-one and 13-ethyl-17β-hydroxy-17α-trifluoromethyl-ster-4,9,11- Trien-3-ones are described in the following documents: Sci.China, Ser.B:Chem.(1997), 40(3), 294-301, CN 94-11218; or Bioorg.Med.Chem.Lett.( 1995), 5(17), 1899-1902. These compounds have progestogenic activity. 17β-Hydroxy-17α-trifluoromethyl-androst-4-en-3-one is d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07J1/00C07J71/00C07J11/00A61K31/565A61P5/26A61K31/569A61K31/58A61P15/00A61P15/10A61P15/16A61P35/00C07J43/00
CPCC07J71/0084C07J71/0047C07J71/0063C07J1/0085C07J11/00C07J1/0037A61P15/00A61P15/10A61P15/16A61P35/00A61P5/26C07J1/00
Inventor 斯文·林京特·考夫曼拉尔夫·维尔沃瓦尔特·埃尔格
Owner SCHERING AG